Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms

• Published in: Frontiers in oncology 2023-09, Vol.13, p.1240359
• Main Authors: Barros, Mario Henrique M, Alves, Paula Daniela S
• Format: Article
• Language: English
• Subjects: EBV-positive nodal T-and NK-cell lymphoma; Epstein-Barr virus; extranodal NK/T-cell lymphoma; infectious mononucleosis; LMP1; Oncology; T-cell lymphoma
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2023.1240359

EBV is a lymphotropic virus, member of the family that asymptomatically infects more than 90% of the human population, establishing a latent infection in memory B cells. EBV exhibits complex survival and persistence dynamics, replicating its genome through the proliferation of infected B cells or production of the lytic virions. Many studies have documented the infection of T/NK cells by EBV in healthy individuals during and after primary infection. This feature has been confirmed in humanized mouse models. Together these results have challenged the hypothesis that the infection of T/NK cells by EBV could be a triggering event for lymphomagenesis. Extranodal NK/T-cell lymphoma (ENKTCL) and Epstein-Barr virus (EBV)-positive nodal T- and NK-cell lymphoma (NKTCL) are two EBV-associated lymphomas of T/NK cells. These two lymphomas display different clinical, histological and molecular features. However, they share two intriguing characteristics: the association with EBV and a geographical prevalence in East Asia and Latin America. In this review we will discuss the genetic characteristics of EBV in order to understand the possible role of this virus in the oncogenesis of ENKTCL and NKTCL. In addition, the main immunohistological, molecular, cytogenetic and epigenetic differences between ENKTCL and NKTCL will be discussed, as well as EBV differences in latency patterns and other viral molecular characteristics.